Login / Signup
Analysis of the Efficacy and Safety of Palonosetron Hydrochloride in Preventing Nausea And Vomiting After TACE: A Retrospective Analysis.
Haohao Lu
Chuansheng Zheng
Bin Liang
Xiangwen Xia
Published in:
Current radiopharmaceuticals (2023)
Palonosetron hydrochloride can significantly reduce the incidence of nausea and vomiting in patients after TACE, with exact effect and high safety.
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
risk factors
patient reported outcomes
patient reported